Aluminum-based adjuvants will continue to be a key component of currently approved and next generation vaccines, including important combination vaccines. The widespread use of aluminum adjuvants is due to their excellent safety profile, which has been established through the use of hundreds of millions of doses in humans over many years. In addition, they are inexpensive, readily available, and are well known and generally accepted by regulatory agencies. Moreover, they offer a very flexible platform, to which many vaccine components can be adsorbed, enabling the preparation of liquid formulations, which typically have a long shelf life under refrigerated conditions. Nevertheless, despite their extensive use, they are perceived as relatively ‘weak’ vaccine adjuvants. Hence, there have been many attempts to improve their performance, which typically involves co-delivery of immune potentiators, including Toll-like receptor (TLR) agonists. This approach has allowed for the development of improved aluminum adjuvants for inclusion in licensed vaccines against HPV, HBV, and COVID-19, with others likely to follow. This review summarizes the various aluminum salts that are used in vaccines and highlights how they are prepared. We focus on the analytical challenges that remain to allowing the creation of well-characterized formulations, particularly those involving multiple antigens. In addition, we highlight how aluminum is being used to create the next generation of improved adjuvants through the adsorption and delivery of various TLR agonists.

More from our Archive

• DOI: 10.3390/pharmaceutics15071916 2023

  Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design

  Lalitkumar K. Vora, Amol D. Gholap, Keshava Jetha, Raghu Raj Singh Thakur, Hetvi K. Solanki, Vivek P. Chavda

• DOI: 10.3390/ph16070934 2023

  A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response

  Ja Bin Hong, Kristin Sophie Lange, Lucas Hendrik Overeem, Paul Triller, Bianca Raffaelli, Uwe Reuter

• DOI: 10.3390/molecules28135145 2023

  Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials

  Manman Xu, Xinpu Han, Hongtai Xiong, Yijie Gao, Bowen Xu, Guanghui Zhu, Jie Li

• DOI: 10.3390/md21070384 2023

  Algal Phycocolloids: Bioactivities and Pharmaceutical Applications

  Silvia Lomartire, Ana M. M. Gonçalves

• DOI: 10.1002/ardp.202300097 2023

  Novel promising benzoxazole/benzothiazole‐derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis

  Hazem Elkady, Khaled El‐Adl, Helmy Sakr, Adel S. Abdelraheem, Sally I. Eissa, Mohamed Ayman El‐Zahabi

• DOI: 10.3390/molecules28135282 2023

  Anti-α-Glucosidase, SAR Analysis, and Mechanism Investigation of Indolo[1,2-b]isoquinoline Derivatives

  Mengyue Li, Lin Li, Li Lu, Xuetao Xu, Jinhui Hu, Jin-Bao Peng

• DOI: 10.3390/pharmaceutics15071906 2023

  Comparison of Bovine- and Porcine-Derived Decellularized Biomaterials: Promising Platforms for Tissue Engineering Applications

  Hussein M. El-Husseiny, Eman A. Mady, Masahiro Kaneda, Kazumi Shimada, Yasumoto Nakazawa, Tatsuya Usui, Mohamed Elbadawy, Yusuke Ishihara, Moeko Hirose, Yohei Kamei, Ahmed S. Doghish, Hesham A. El-Mahdy, Walaa A. El-Dakroury, Ryou Tanaka

• DOI: 10.1002/adhm.202301010 2023

  Clinical Translation of Extracellular Vesicles

  Aayushi Ghodasara, Aun Raza, Joy Wolfram, Carlos Salomon, Amirali Popat

• DOI: 10.3390/molecules28135186 2023

  Homogeneous Electrochemical Aptamer Sensor Based on Two-Dimensional Nanocomposite Probe and Nanochannel Modified Electrode for Sensitive Detection of Carcinoembryonic Antigen

  Zhengzheng Yan, Shiyue Zhang, Jiyang Liu, Jun Xing

• DOI: 10.3390/molecules28145407 2023

  Recent Developments and Applications of Microbial Levan, A Versatile Polysaccharide-Based Biopolymer

  Marta Domżał-Kędzia, Monika Ostrowska, Agnieszka Lewińska, Marcin Łukaszewicz